AJP - Lung AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 272: L608-L613, 1997;
1040-0605/97 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vepa, S.
Right arrow Articles by Natarajan, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vepa, S.
Right arrow Articles by Natarajan, V.

AJP - Lung Cellular and Molecular Physiology, Vol 272, Issue 4 608-L613, Copyright © 1997 by American Physiological Society

ARTICLES

Activation of endothelial cell phospholipase D by polycations

S. Vepa, W. M. Scribner and V. Natarajan
Department of Medicine, Indiana University School of Medicine, Indianapolis 46202-2879, USA.

Naturally occurring polycations and cationic proteins are implicated in vascular disorders. It is known that activated leukocytes and platelets release polycations, such as polylysine (PLys), of varying molecular sizes into the vasculature, and some of these have been described to be bactericidal. Polycations interact with endothelial cells (ECs) and cause alterations in permeability and cellular functions. The precise mechanism(s) by which polycations bring about cellular changes is unknown. Here, we report that the polycations PLys and polyarginine (PArg) induce phospholipase D (PLD) activation in ECs. Polycation-mediated PLD activation was both time and concentration dependent, and activation of PLD was not due to cytotoxicity. PArg was more potent compared with PLys of the same molecular weight in stimulation of PLD. Treatment with bisindolylmaleimide, a specific protein kinase C (PKC) inhibitor, and heparin attenuated polycation-mediated PLD activation. Furthermore, downregulation of PKC by 12-O-tetradecanoylphorbol-13-acetate (100 nM, 18 h) also blocked polycation-mediated PLD stimulation. These data suggest that polycation-mediated PLD stimulation probably involves PKC and may represent an important cellular response to leukocyte/platelet activation in the vascular endothelium.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. O. Dull, R. Dinavahi, L. Schwartz, D. E. Humphries, D. Berry, R. Sasisekharan, and J. G. N. Garcia
Lung endothelial heparan sulfates mediate cationic peptide-induced barrier dysfunction: a new role for the glycocalyx
Am J Physiol Lung Cell Mol Physiol, November 1, 2003; 285(5): L986 - L995.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Cameron, J. Appel, R. A. Houghten, and I. Lindberg
Polyarginines Are Potent Furin Inhibitors
J. Biol. Chem., November 17, 2000; 275(47): 36741 - 36749.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online